Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 4, 2012, Pages 442-450

  Lopes, R ^a   Eleuterio C V ^a   Gonalves, L M D ^a   Cruz, M E M ^a   Almeida, A J ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Dinitroanilines; Leishmaniasis; Lipid nanoparticles; Oryzalin; Stability; Sterilization

Indexed keywords

ANILINE DERIVATIVE; DRUG CARRIER; LIPID; ORYZALIN; PHOSPHATIDYLCHOLINE; POLYSORBATE 20; SOLID LIPID NANOPARTICLE; SURFACTANT; TRIPALMITIN; UNCLASSIFIED DRUG;

AUTOCLAVE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG STABILITY; EMULSION; FREEZE DRYING; HUMAN; HUMAN CELL; LEISHMANIASIS; LIPID COMPOSITION; NANOENCAPSULATION; PARENTERAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE CHARGE; ZETA POTENTIAL;

ANTIPROTOZOAL AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCHOLIC ACID; DINITROBENZENES; DRUG STABILITY; HUMANS; LECITHINS; LEISHMANIASIS; NANOPARTICLES; PARTICLE SIZE; POLYSORBATES; SULFANILAMIDES; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 84856287868     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.09.017     Document Type: Conference Paper

References (53)

1. N.P. Aditya, S. Patankar, B. Madhusudhan, R.S.R. Murthy, and E.B. Souto Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity Eur. J. Pharm. Sci. 40 2010 448 455
2. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug. Deliv. Rev. 59 2007 478 490 (Pubitemid 47260710)
3. A. Armson, S.W. Kamau, F. Grimm, J.A. Reynoldson, W.M. Best, L.M. MacDonald, and R.C. Thompson A comparison of the effects of a benzimidazole and the dinitroanilines against Leishmania infantum Acta Tropica. 73 1999 303 311 (Pubitemid 29528121)
4. A.A. Attama, B.C. Schicke, T. Paepenmüller, and C.C. Müller-Goymann Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization Eur. J. Pharm. Biopharm. 67 2007 48 57 (Pubitemid 46991314)
5. J.D. Berman Development of miltefosine for the leishmaniases Mini Rev. Med. Chem. 6 2006 145 151
6. G. Bhattacharya, M.M. Salem, and K.A. Werbovetz Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin Bioorg. Med. Chem. Lett. 12 2002 2395 2398 (Pubitemid 34879874)
7. C. Bogdan, G. Schönian, A.L. Bañuls, M. Hide, F. Pratlong, E. Lorenz, M. Röllinghoff, and R. Mertens Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature Clin. Infect. Dis 32 2001 302 306 (Pubitemid 32524804)
8. H. Bunjes, and M.H.J. Koch Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles J. Control Release 107 2005 229 243 (Pubitemid 41316286)
9. H. Bunjes, M.H.J. Koch, and K. Westesen Influence of emulsifiers on the crystallization of solid lipid nanoparticles J. Pharm. Sci. 92 2003 1509 1520 (Pubitemid 36792763)
10. M. Carvalheiro, J. Jorge, C. Eleutério, A.F. Pinhal, A.C. Sousa, J.G. Morais, and M.E.M. Cruz Trifluralin liposomal formulations active against Leishmania donovani infections Eur. J. Pharm. Biopharm. 71 2009 292 296
11. E. Cauchetier, M. Paul, D. Rivollet, H. Fessi, A. Astier, and M. Deniau Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis Int. J. Parasitol. 30 2000 777 783 (Pubitemid 30336458)
12. R. Cavalli, O. Caputo, M.E. Eugenia, M. Trotta, C. Scarnecchia, and M.R. Gasco Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int. J. Pharm. 148 1997 47 54 (Pubitemid 27152216)
13. M.M. Chan, and D. Fong Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin Science 249 1990 924 926
14. P. Desjeux The increase in risk factors for leishmaniasis worldwide Trans. R. Soc. Trop. Med. Hyg. 95 2001 239 243 (Pubitemid 33713068)
15. P. Desjeux, and J. Alvar Leishmania/HIV co-infections: epidemiology in Europe Ann. Trop. Med. Parasitol. 97 1 2003 3 15
16. J.C. Dujardin Spread of vector-borne diseases and neglect of leishmaniasis Europe. Emerg. Infect. Dis. 14 2008 1013 1018
17. M.A. Esteves, I. Fragiadaki, R. Lopes, E. Scoulica, and M.E.M. Cruz Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents Bioorg. Med. Chem. 18 2010 274 281
18. European Medicines Agency, 1998. GMP guideline CPMP/QWP/054/98 annex to note for guidance on development pharmaceutics (CPMP/QWP/155/96): decision trees for selection of sterilisation methods. Available at: http://www.gmp- compliance.org/eca-guideline-68.html [Accessed December 14, 2010].
19. B.J. Fennell, J.A. Naughton, E. Dempsey, and A. Bell Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: tubulin as a specific antimalarial target Mol. Biochem. Parasitol. 145 2006 226 238 (Pubitemid 43083364)
20. C. Freitas, and R.H. Muller Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions Int. J. Pharm. 168 1998 221 229 (Pubitemid 28349963)
21. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Güneri, and C. Caramella Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 2008 76 86
22. S. Kheradmandnia, E. Vasheghani-Farahani, M. Nosrati, and F. Atyabi Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax Nanomedicine 1 2010 7
23. R. Killick-Kendrick Phlebotomine vectors of the leishmaniases: a review Med. Vet. Entomol. 4 1990 1 24
24. J. Kuntsche, and H. Bunjes Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles Eur. J. Pharm. Biopharm. 67 2007 612 620 (Pubitemid 47576621)
25. A. Lemke, A.F. Kiderlen, and O. Kayser Amphotericin B. Appl. Microbiol. Biotechnol 68 2005 151 162 (Pubitemid 41110936)
26. S.-J. Lim, and C.-K. Kim Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid Int. J. Pharm. 243 2002 135 146
27. C. Marques, M. Carvalheiro, M.A. Pereira, J. Jorge, M.E.M. Cruz, and G.M. Santos-Gomes Efficacy of the liposome trifluralin in the treatment of experimental canine leishmaniosis Vet. J. 178 2008 133 137
28. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug. Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
29. F. Modabber Leishmaniasis vaccines: past, present and future Int. J. Antimicrob. Agents. 2010 22 25
30. L. Monzote Current treatment of leishmaniasis: a review Open Antimicrob. Agents J. 1 2009 9 19
31. N.S. Morrissette, A. Mitra, D. Sept, and L.D. Sibley Dinitroanilines bind alpha-tubulin to disrupt microtubules Mol. Biol. Cell. 15 2004 1960 1968 (Pubitemid 38401842)
32. A. zur Mühlen, C. Schwarz, and W. Mehnert Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism Eur. J. Pharm. Biopharm. 45 1998 149 155 (Pubitemid 28167741)
33. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177 (Pubitemid 30326695)
34. A.P. Nayak, W. Tiyaboonchai, S. Patankar, B. Madhusudhan, and E.B. Souto Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment Colloids Surf. B. Biointerfaces. 81 2010 263 273
35. S. Nema, R.J. Brendel, and R. Washkuhn Excipients: Parenteral Dosage Forms and Their Role J. Swarbrick, Encyclopedia of Pharmaceutical Technology 2007 Informa Healthcare USA, Inc. New York 1622 1645
36. E.K. Noriega-Peláez, N. Mendoza-Muñoz, A. Ganem-Quintanar, and D. Quintanar-Guerrero Optimization of the emulsification and solvent displacement method for the preparation of solid lipid nanoparticles Drug Dev. Ind. Pharm. 37 2011 160 166
37. A.Y. Nyporko, A.I. Yemets, V.N. Brytsun, M.O. Lozinsky, and Y.B. Blume Structural and biological characterization of the tubulin interaction with dinitroanilines Cytol. Genet. 43 2009 267 282
38. A. Papagiannaros, C. Bories, C. Demetzos, and P.M. Loiseau Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations Biomed. Pharmacother. 59 2005 545 550 (Pubitemid 41820384)
39. G. Powis, A. Gallegos, R.T. Abraham, C.L. Ashendel, L.H. Zalkow, R. Dorr, K. Dvorakova, S. Salmon, S. Harrison, and J. Worzalla Inhibition of intracellular Ca2+ signalling, cytotoxicity and antitumor activity of the herbicide oryzalin and its analogues Cancer Chemother. Pharmacol. 41 1997 22 28 (Pubitemid 28093946)
40. M. Rittig Leishmania host-cell interaction: complexities and alternative views Parasitol. Today 16 2000 292 297 (Pubitemid 30447394)
41. U. Ruktanonchai, U. Sakulkhu, P. Bejrapha, P. Opanasopit, N. Bunyapraphatsara, V. Junyaprasert, and S. Puttipipatkhachorn Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles J. Microencapsul. 26 2009 614 626
42. M.A. Schubert, and C.C. Mu Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier Eur. J. Pharm. Biopharm. 61 2005 77 86 (Pubitemid 41096691)
43. M.A. Schubert, and B.C. Schicke Thermal analysis of the crystallization and melting behavior of lipid matrices and lipid nanoparticles containing high amounts of lecithin Int. J. Pharm. 298 2005 242 254 (Pubitemid 40828345)
44. T.J. Stokkermans, J.D. Schwartzman, K. Keenan, N.S. Morrissette, L.G. Tilney, and D.S. Roos Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides Exp. Parasitol. 84 1996 355 370 (Pubitemid 26412997)
45. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang Formulation and characterization of curcuminoids loaded solid lipid nanoparticles Int. J. Pharm. 337 2007 299 306 (Pubitemid 46756048)
46. Y.M. Traub-Cseko, J.M. Ramalho-Ortigão, A.P. Dantas, S.L. Castro, H.S. de Barbosa, and K.H. Downing Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi Trends Parasitol. 17 2001 136 141 (Pubitemid 32422182)
47. M. Uner, and G. Yener Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives Int. J. Nanomedicine 2 2007 289 300 (Pubitemid 350047774)
48. V. Vanlerberghe, G. Diap, P.J. Guerin, F. Meheus, S. Gerstl, P. Van der Stuyft, and M. Boelaert Drug policy for visceral leishmaniasis: a cost-effectiveness analysis Trop. Med. Int. Health 12 2007 274 283
49. V. Venkateswarlu, and K. Manjunath Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Control Release 95 2004 627 638 (Pubitemid 38344153)
50. K. Vivek, H. Reddy, and R.S.R. Murthy Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles AAPS Pharm. Sci. Tech. 8 2007 E83
51. World Health Organisation, 2010. Leishmaniasis. Available at: http://www.who.int/leishmaniasis/en/ [Accessed December 13, 2010].
52. D. Wu, T.G. George, E. Hurh, K.A. Werbovetz, and J.T. Dalton Pre-systemic metabolism prevents in vivo antikinetoplastid activity of N1, N4-substituted 3, 5-dinitro sulfanilamide, GB-II-150 Life sci. 79 2006 1081 1093 (Pubitemid 44067070)
53. S.-A. Zhang, J.-H. Hu, Q.-W. Li, and Z.-L. Jiang The cryoprotective effects of soybean lecithin on boar spermatozoa quality J. Biotechnol. 8 2009 6476 6480